All Infection Prevention & Control articles – Page 3
-
NewsMeningitis, hangover or freshers’ flu? Don’t dismiss serious symptoms
Students heading into freshers’ week are being warned not to assume a headache, vomiting or feeling wiped out is simply the result of a heavy night or the dreaded “freshers’ flu”. 246,089 doses of the MenB vaccine were administered to young people in England between 20 July and 31 August.
-
NewsResearchers find C. difficile colonization in infants reshapes gut development
Practically since its discovery, the highly contagious bacterium Clostridioides difficile has been reported to not cause symptoms in infants. But new findings suggest that the bacterium can reshape the developing infant gut and may have long-term consequences.
-
NewsResearchers test far-ultraviolet light to prevent bird flu in poultry
Researchers are preparing to test a new potential line of defense against highly pathogenic avian influenza, HPAI in poultry farming. They will use a form of ultraviolet light called far-UVC, to see if it can kill HPAI, without harming birds on poultry farms.
-
NewsMosaic nanoparticles deliver broad-spectrum mucosal protection against diverse coronaviruses
Researchers have developed a novel “mosaic” nanoparticle vaccine platform that successfully penetrates the mucus barrier to deliver broad-spectrum mucosal protection against a diverse array of coronaviruses, including highly evasive SARS-like and MERS-like strains.
-
NewsMXene-based hydrogel disrupt bacterial biofilms and reprogram immune cell metabolism to reverse bone resorption in periodontitis
Researchers have developed an injectable MXene-based composite hydrogel (GQM) for the treatment of periodontitis. The hydrogel consists of oxidized gellan gum (OG), quaternized chitosan (QCS), and magnesium-tannic acid modified MXene nanosheets (MTA-Mg).
-
NewsStudy sheds light on how bacteria assemble outer membrane proteins
Researchers analyzed the various conformations that a chaperone protein adopts while delivering unfolded outer membrane proteins to the assembly machinery.
-
NewsDifference in clinical characteristics and outcomes between hospital-acquired and community-acquired pleural infection
A critical aspect of managing pleural infection is understanding differences between hospital-acquired and community-acquired forms, as these two entities differ fundamentally in etiology, microbiology, antimicrobial resistance patterns, and patient populations.
-
NewsMicro-bladder model offers clues to stopping recurrent UTIs
A new study shows that phage therapy – the use of tiny viruses to kill bacteria without harming people – could help to reduce recurrent infections, which happen when the bacteria responsible for UTIs ‘hide’ in the tissue of the bladder.
-
NewsVaricella zoster virus can cause serious disease beyond chickenpox and shingles
New research is shedding light on the surprisingly broad range of neurological and systemic diseases that can be caused by varicella zoster virus (VZV), the virus that causes chickenpox and shingles.
-
NewsThe push to understand and treat HPV
Karl Munger is helping to lead an effort at Tufts University and Tufts Medicine that brings research scientists together with clinicians to save lives through improved HPV care and research.
-
NewsCancer medication helps reduce SIV reservoir, increases hope for HIV cure
Researchers have provided the first proof-of-concept in a nonhuman primate model for eliminating HIV-infected cells with venetoclax, a clinically approved medication for cancer.
-
NewsERC Starting Grant for Tom Beneke: Drug resistance in tropical parasites
Molecular biologist Dr Tom Beneke (35) from the Biozentrum at the University of Würzburg has been awarded a €1.5 million ERC grant to further advance his research on Leishmania and the disease they cause.
-
NewsInvasive mosquito species detected in east London
The UK Health Security Agency (UKHSA) is undertaking enhanced surveillance and trapping activities following the detection of invasive Aedes aegypti mosquitoes and larvae at nearby residential properties in east London.
-
NewsImmune drug anifrolumab linked to lower risk of infection and hospitalization for skin lupus
Preliminary results from an investigator-initiated single-site clinical study show that some people with chronic cutaneous lupus erythematosus are less likely to acquire life-threatening infections when taking the drug anifrolumab.
-
NewsNew design strategy expands nanoparticle vaccine approach to influenza viruses
Research scientists have developed a blueprint for stabilizing key influenza proteins and using them to make next-generation vaccine candidates.
-
NewsAntifungal therapy shows potential for IBD patients with candida overgrowth
A commonly used systemic antifungal medication may help reduce symptoms in a subset of patients with inflammatory bowel disease (IBD) by restoring a healthier gut microbiome, according to a preliminary study.
-
NewsAnti-influenza therapies that target the host
Researchers suggest that nucleolin-binding drugs are a promising avenue of research in the quest to overcome drug resistance and improve influenza management worldwide.
-
NewsGoniothalamin as a dual-target medicinal chemistry candidate against antibiotic-resistant bacteria
A new computational study has found that goniothalamin — a natural plant compound — binds tightly to two critical bacterial proteins in drug-resistant Staphylococcus aureus and Escherichia coli, suggesting it could form the basis of a new class of antibacterial agents.
-
NewsPediatric investigation review emphasizes the evolving landscape of pediatric enterovirus infections
A review article highlights how rapid viral evolution of enteroviruses combined with shifting dominant strains and antigenic variation present a major obstacle to EV prevention and control in children.
-
NewsSemen facilitates infection with mpox virus
Researchers have found that seminal fluid can facilitate infection of skin cells with the mpox virus. An analysis of the seminal fluid showed that certain naturally occurring protein fragments are responsible for this effect.